Management of Biliary Diseases in Pregnancy
Laparoscopic cholecystectomy is the standard of care for symptomatic gallstone disease during pregnancy, regardless of trimester, though ideally performed in the second trimester. 1
Gallstone Disease Management
Surgical Management
- Laparoscopic cholecystectomy is superior to conservative management for symptomatic cholelithiasis in the first or second trimester 1
- Safety has been demonstrated across all trimesters, though the second trimester is ideal 1
- Same-admission cholecystectomy for acute biliary pancreatitis reduces 30-day readmission rates significantly (5.3% vs 33.7%) 1
- For late third trimester presentations, postponing surgery until after delivery may be reasonable if it doesn't pose immediate maternal or fetal health risks 1
Alternative Interventions
- For patients who are hemodynamically unstable, unresponsive to medical management, or high-risk for surgery:
- Percutaneous cholecystostomy tube placement
- Percutaneous gallbladder aspiration
- These serve as "bridging" therapies until definitive cholecystectomy can be performed 1
Positioning During Surgery
- After first trimester, patients should be placed in left lateral or partial left lateral decubitus position to minimize inferior vena cava compression 1
ERCP Management
Radiation Safety Measures
- Multidisciplinary team approach including obstetrician, perinatologist, radiation safety officer, anesthesiologist, and experienced endoscopist 1
- Technical considerations:
- Modern fluoroscopy unit with collimation and pulsed fluoroscopy
- Last image hold feature and short taps of fluoroscopy
- Avoid spot films and use of magnification
- Position image intensifier close to patient, keeping patient away from radiation source
- Low radiation dose protocols and low frame rates 1
- Alternative techniques to reduce radiation:
- Bile aspiration technique
- Cholangioscopy
- Endoscopic ultrasound 1
- For large stones, consider stent placement and postpone lithotripsy until after delivery 1
- Avoid pelvic and gonadal shielding as radiation from newer fluoroscopy machines may penetrate lead and increase exposure 1
Patient Positioning for ERCP
- First trimester: Supine or prone position acceptable
- Second and third trimesters: Left pelvic tilt or left lateral position to avoid aorta or inferior vena cava compression 1
Specific Biliary Conditions in Pregnancy
Intrahepatic Cholestasis of Pregnancy (ICP)
- First-line treatment: Ursodeoxycholic acid (UDCA) 10-15 mg/kg/day in divided doses 2
- Delivery timing based on bile acid levels:
- High risk (≥100 μmol/L): Deliver at 36 weeks or at diagnosis if after 36 weeks
- Moderate risk (40-99 μmol/L): Deliver between 36-39 weeks
- Lower risk (<40 μmol/L): Deliver at 37-39 weeks 2
- Monitor total serum bile acids and liver function tests every 2 weeks until 32 weeks, then weekly 2
Primary Biliary Cholangitis (PBC) and Primary Sclerosing Cholangitis (PSC)
- Continue UDCA during pregnancy and breastfeeding 1
- For worsening pruritus, treatment options include:
- Rifampicin (300-600 mg daily)
- Anion exchange resins (cholestyramine 4-8 g/day or colestipol 5-10 g/day) given at least 4 hours after UDCA 1
- For PSC with worsening cholestasis, perform ultrasound or MRI to exclude obstruction 1
- Endoscopic balloon dilatation or short-term bile duct stenting for high-grade biliary strictures 1
Common Pitfalls and Caveats
Conservative management risks:
Radiation concerns:
Timing of interventions:
By following these evidence-based approaches, biliary diseases in pregnancy can be managed effectively while minimizing risks to both mother and fetus.